Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Thymic stromal lymphopoietin (TSLP), interleukin-25 (IL-25), and IL-33 are important initiators of type 2-associated mucosal inflammation and immunity. However, their role in the maintenance of progressive type 2 inflammation and fibrosis is much less clear. Using chronic models of helminth infection and allergic lung inflammation, we show that collective disruption of TSLP, IL-25, and IL-33 signaling suppresses chronic and progressive type 2 cytokine-driven inflammation and fibrosis. In a schistosome lung granuloma model or during chronic Schistosoma mansoni infection in the liver, individual ablation of TSLP, IL-25, or IL-33/ST2 had no impact on the development of IL-4/IL-13-dependent inflammation or fibrosis. However, significant reductions in granuloma-associated eosinophils, hepatic fibrosis, and IL-13-producing type 2 innate lymphoid cells (ILC2s) were observed when signaling of all three mediators was simultaneously disrupted. Combined blockade through monoclonal antibody (mAb) treatment also reduced IL-5 and IL-13 expression during primary and secondary granuloma formation in the lungs. In a model of chronic house dust mite-induced allergic lung inflammation, combined mAb treatment did not decrease established inflammation or fibrosis. TSLP/IL-33 double-knockout mice treated with anti-IL-25 mAb during priming, however, displayed decreased inflammation, mucus production, and lung remodeling in the chronic phase. Together, these studies reveal partially redundant roles for TSLP, IL-25, and IL-33 in the maintenance of type 2 pathology and suggest that in some settings, early combined targeting of these mediators is necessary to ameliorate progressive type 2-driven disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“integrin receptors that interact with the extracellular matrix were recently shown to preferentially activate TGF-β signaling and production of IL-17A while antagonizing the production of type 2 cytokines142”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [142]
In the citing paper
“several studies have revealed substantial cross-regulation between IL-17A and IL-13110,143, with marked upregulation of the opposing pathway when only one mechanism was targeted therapeutically136,142,144,145”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [142]
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450 · cited 1×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundSchmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationPetry, F. E. (1997) · Kluwer Academic Publishers eBooks · Cited by 2,303
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765 · cited 2×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundSelf-citationMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314 · cited 1×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundIL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Research works printed but not linked: 1
- T. A. Wynn L. Barron R. W. Thompson S. K. Madala M. S. Wilson A. W. Cheever T. Ramalingam in Current Protocols in Immunology John E. Coligan et al. Eds. (John Wiley & Sons Inc. New York 2011).
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationLiver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Inflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369
Self-citationInterleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citationShared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Apoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
The Formation and Function of Granulomas
Pagán, A. J., & Ramakrishnan, L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100022 · Cited by 430
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
“s a pyrogen (292) Fibrosis (293) ion, macrophage Tissue regeneration, asthma, T-cell immunity (295–297) s a pyrogen (17) Broad involvement with inflammatory pathologies (17) Histological inflammation (298) 6) Scarless fetal healing (299) T-cell immunity (300) Tissue regeneration, asthma, T-cell immunity (295–297, 302)…”
BackgroundType 2 immunity: Expanding our view
Lloyd, C. M., & Snelgrove, R. J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1604 · Cited by 334
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
Kelsen, S. G., Agache, I. O., Soong, W., Israel, E., Chupp, G. L., Cheung, D. S., Theess, W., Yang, X., Staton, T. L., Choy, D. F., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.044 · Cited by 319
Kohlgruber, A. C., Gal-Oz, S. T., LaMarche, N. M., Shimazaki, M., Duquette, D., Koay, H.-F., Nguyen, H. N., Mina, A. I., Paras, T., Tavakkoli, A., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0094-2 · Cited by 319
Han, H., Roan, F., & Ziegler, S. F. (2017) · Immunological Reviews · doi:10.1111/imr.12546 · Cited by 285
Schistosoma “Eggs-Iting” the Host: Granuloma Formation and Egg Excretion
Schwartz, C., & Fallon, P. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02492 · Cited by 235
“While individual ablation of each of these cytokines did not impair hepatic granuloma formation in chronic schistosomiasis, the combinatorial targeting of all three cytokines led to reduced hepatic fibrosis, impaired eosinophil recruitment and fewer numbers of IL-13-producing ILC2 (106).”
BackgroundInfluentialMcGinty, J. W., Ting, H.-A., Billipp, T. E., Nadjsombati, M. S., Khan, D. M., Barrett, N. A., Liang, H.-E., Matsumoto, I., & von Moltke, J. (2020) · Immunity · doi:10.1016/j.immuni.2020.02.005 · Cited by 231
“We consider it likely that cysLTs and NMU serve both redundant and non-overlapping roles in the SI, as is often the case in type 2 immunity (Neill et al., 2010; Vannella et al., 2016).”
BackgroundSchistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
Costain, A. H., MacDonald, A. S., & Smits, H. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03042 · Cited by 222
“However, such effects were transient in nature and no longer significant by 12 weeks post infection, suggesting that these alarmins are dispensable for the development and maintenance of egg-induced pathology (120).”
BackgroundCoakley, G., McCaskill, J. L., Borger, J. G., Simbari, F., Robertson, E., Millar, M., Harcus, Y., McSorley, H. J., Maizels, R. M., & Buck, A. H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.001 · Cited by 219
“In support of this, a recent study showed that disruption of ST2 signaling had no effect on type 2-mediated responses, including IL-4 release, following challenge by S. mansoni (Vannella et al., 2016).”
ResultZhang, W.-J., Chen, S.-J., Zhou, S.-C., Wu, S.-Z., & Wang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643149 · Cited by 209
Camelo, A., Rosignoli, G., Ohne, Y., Stewart, R. A., Overed-Sayer, C., Sleeman, M. A., & May, R. D. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002352 · Cited by 200
“Studies in mouse models suggest that IL-33 may be more potent than IL-25 or TSLP in directing allergic inflammation in the lungs via ILC activation,(4) while redundancy among the 3 cytokines was found with respect to their role during chronic inflammation and fibrosis.(6)”
BackgroundStructure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma
Verstraete, K., Peelman, F., Braun, H., Lopez, J., Van Rompaey, D., Dansercoer, A., Vandenberghe, I., Pauwels, K., Tavernier, J., Lambrecht, B. N., et al. (2017) · Nature Communications · doi:10.1038/ncomms14937 · Cited by 190
Macrophages, Wound Healing, and Fibrosis: Recent Insights
Smigiel, K. S., & Parks, W. C. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0725-5 · Cited by 175
Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics
Porsbjerg, C. M., Sverrild, A., Lloyd, C. M., Menzies-Gow, A. N., & Bel, E. H. (2020) · European Respiratory Journal · doi:10.1183/13993003.00260-2020 · Cited by 174
“Using chronic models of helminth infection and T2 cytokine-driven lung inflammation, targeting all three alarmins (TSLP, IL-25 and IL-33) was found to be more efficacious than blocking a single alarmin alone [106].”
BackgroundFurue, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113741 · Cited by 168
“In a murine Schistosoma mansoni infection model, individual knockout treatment of each of Tslp, Il25, and Il33 was shown not to interfere with IL-13/IL-4 production and subsequent fibrosis, whereas simultaneous knockdown of Tslp, Il25, and Il33 was found to block the IL-13/IL-4 production and subsequent fibrosis [137].”
BackgroundInfluentialRecent advances in understanding the role of IL-4 signaling
Keegan, A. D., Leonard, W. J., & Zhu, J. (2021) · Faculty Reviews · doi:10.12703/r/10-71 · Cited by 154
T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis
Zheng, B., Zhang, J., Chen, H., Nie, H., Miller, H. E., Gong, Q., & Liu, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00061 · Cited by 156
“They showed that simultaneous disruption of IL33, IL-25, and TSLP signaling inhibited the progression of Th2 cytokine-driven liver fibrosis but that individual disruption of each had no effect (48).”
BackgroundConventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis
Kokubo, K., Onodera, A., Kiuchi, M., Tsuji, K., Hirahara, K., & Nakayama, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945063 · Cited by 167
TSLP, IL-33, and IL-25: Not just for allergy and helminth infection
Stanbery, A. G., Smita, S., von Moltke, J., Wojno, E. D. T., & Ziegler, S. F. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.07.003 · Cited by 151
Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response
Duchesne, M., Okoye, I., & Lacy, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975914 · Cited by 154
Heterogeneity in the initiation, development and function of type 2 immunity
Gause, W. C., Rothlin, C., & Loke, P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0301-x · Cited by 119
Allinne, J., Scott, G., Lim, W. K., Birchard, D., Erjefält, J. S., Sandén, C., Ben, L.-H., Agrawal, A., Kaur, N., Kim, J. H., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.039 · Cited by 118
Fra-2–expressing macrophages promote lung fibrosis
Ucero, A. C., Bakiri, L., Roediger, B., Suzuki, M., Jiménez, M., Mandal, P., Braghetta, P., Bonaldo, P., Paz-Ares, L. G., Torre, C. F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125366 · Cited by 131
“The contribution of type 2 cytokines, IL-4 and IL-13, to macrophage activation and fibrosis development in different organs is well accepted (4, 47, 48).”
BackgroundSpontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease
Van Dyken, S. J., Liang, H.-E., Naikawadi, R. P., Woodruff, P. G., Wolters, P. J., Erle, D. J., & Locksley, R. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.044 · Cited by 104
Ravanetti, L., Dijkhuis, A., Dekker, T., Piñeros, Y. S. S., Ravi, A., Dierdorp, B., Erjefalt, J. S., Mori, M., Pavlidis, S. P., Adcock, I. M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.051 · Cited by 110
Pulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170499 · Cited by 95
Wang, E., Liu, X., Tu, W., Do, D. C., Yu, H., Yang, L., Zhou, Y., Xu, D., Huang, S., Yang, P., et al. (2019) · Allergy · doi:10.1111/all.13784 · Cited by 88
Therapeutic monoclonal antibodies in allergy: Targeting IgE , cytokine, and alarmin pathways
Eggel, A., Pennington, L. F., & Jardetzky, T. S. (2024) · Immunological Reviews · doi:10.1111/imr.13380 · Cited by 94
Pulmonary group 2 innate lymphoid cells: surprises and challenges
Starkey, M. R., McKenzie, A. N. J., Belz, G. T., & Hansbro, P. M. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0130-4 · Cited by 86
“mansonii infection and HDMinduced allergic lung inflammation.(164) Inhibition of IL-33 activity or depletion of alveolar macrophages decreased, whereas treatment with rIL-33 or adoptive transfer of ILC2s increased, inflammation and fibrosis.”
Deckers, J., Bosscher, K. D., Lambrecht, B. N., & Hammad, H. (2017) · Immunological Reviews · doi:10.1111/imr.12542 · Cited by 83
Verma, M., Liu, S., Michalec, L., Sripada, A., Gorska, M. M., & Alam, R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.020 · Cited by 78
“Complete resolution of experimental asthma and lung inflammation was observed only when all 3 type 2–inducing epithelial cytokines, IL-25, IL-33 and thymic stromal lymphopoietin (TSLP), or their receptors were blocked.(17) Interestingly, most of these studies were performed in acute asthma models or in a model of chro…”
InfluentialThe ins and outs of innate and adaptive type 2 immunity
Molofsky, A. B., & Locksley, R. M. (2023) · Immunity · doi:10.1016/j.immuni.2023.03.014 · Cited by 80
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation
Floudas, A., Saunders, S. P., Moran, T., Schwartz, C., Hams, E., Fitzgerald, D. C., Johnston, J. A., Ogg, G. S., McKenzie, A. N., Walsh, P. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602185 · Cited by 69
Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease
Donovan, C., Starkey, M. R., Kim, R., Rana, B. M. J., Barlow, J. L., Jones, B., Haw, T. J., Nair, P. M., Budden, K. F., Cameron, G. J. M., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab0518-178r · Cited by 70
“43,44 CS exposure increased lung Il 33 expression in WT mice, which was further increased in CS-exposed ILC2-deficient mice (Fig.”
Zhu, Y., Peng, X., Zhang, Y., Lin, J., & Zhao, G. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.26 · Cited by 65
Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis
Odell, I. D., Steach, H. R., Gauld, S. B., Reinke-Breen, L., Kármán, J., Carr, T. L., Wetter, J. B., Phillips, L. A., Hinchcliff, M., & Flavell, R. A. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq6691 · Cited by 87
“Elevated expression of alarmins links inflammation and fibrosis (e.g. (47)) and correlates with dcSSc severity in patients (48), supporting EREG + APC in SSc pathogenesis as part of a tissue damage response.”
The use of biologics for immune modulation in allergic disease
van de Veen, W., & Akdiş, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124607 · Cited by 67
“Similar results were found in a model of house dust mite–induced allergic airway hypersensitivity (117).”
BackgroundResultIL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammation
Holgado, A., Braun, H., Nuffel, E. V., Detry, S., Schuijs, M. J., Deswarte, K., Vergote, K., Haegman, M., Baudelet, G., Haustraete, J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.02.028 · Cited by 63
Targeting alarmins in asthma: From bench to clinic
Akenroye, A. T., Boyce, J. A., & Kita, H. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.01.017 · Cited by 67
Host Immunity and Inflammation to Pulmonary Helminth Infections
Weatherhead, J. E., Gazzinelli-Guimarães, P. H., Knight, J. M., Fujiwara, R. T., Hotez, P. J., Bottazzi, M. E., & Corry, D. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594520 · Cited by 78
“Initial Th2-cell differentiation largely involves the cytokines IL-2, IL-4, and collectively IL-25, TSLP, and IL-33 as well as the transcription factor GATA3 directing effector function in the lungs (95, 97, 98).”
BackgroundKoh, B., Ulrich, B. J., Nelson, A. S., Panangipalli, G., Kharwadkar, R. P., Wu, W., Xie, M. M., Fu, Y., Turner, M. J., Paczesny, S., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.002 · Cited by 59
The immunology of asthma and chronic rhinosinusitis
Kato, A., & Kita, H. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01159-0 · Cited by 76
“The effects of TSLP, IL-33 and IL-25 on type 2 immunity were additive or synergistic depending on their environment 47 .”
Dichotomous function of IL-33 in health and disease: From biology to clinical implications
Braun, H., Afonina, I. S., Mueller, C., & Beyaert, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.010 · Cited by 53
IL ‐33 signalling contributes to pollutant‐induced allergic airway inflammation
Grove, K. C. D., Provoost, S., Braun, H., Blomme, E. E., Teufelberger, A. R., Krysko, O., Beyaert, R., Brusselle, G., Joos, G., & Maes, T. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13261 · Cited by 51
“Moreover, it would be interesting to examine the functional role of other epithelial type 2‐promoting cytokines, for example, IL‐25 and TSLP, during DEP‐enhanced allergic airway inflammation, as it was suggested that combinatorial blockage of these cytokines could be necessary to effectively inhibit lung inflammation.…”
BackgroundInterleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells
Weiskirchen, R., & Tacke, F. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.62 · Cited by 48
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
Kayongo, A., Nyiro, B., Siddharthan, T., Kirenga, B., Checkley, W., Joloba, M. L., Ellner, J. J., & Salgame, P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1146571 · Cited by 58
“Besides CXCL5 production by epithelial cells, alarmins (IL-25, IL-33, TSLP) (Vannella et al., 2016; Gupta et al., 2017; Roan et al., 2019) as well as cytokine production (IL-1b, IL-8, and G-CSF) (Wickremasinghe et al., 1999; Roan et al., 2019) results in further mobilization of innate lymphoid cells (ILCs).”
BackgroundInhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions
Zhang, M., Lu, H., Xie, L., Liu, X., Cun, D., & Yang, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115144 · Cited by 56
Mishra, P. K., Palma, M., Buechel, B., Moore, J., Davra, V., Chu, N., Millman, A., Hallab, N. J., Kanneganti, T., Birge, R. B., et al. (2019) · Nature Materials · doi:10.1038/s41563-018-0271-6 · Cited by 45
Airway mycosis in allergic airway disease
Li, E., Knight, J. M., Wu, Y., Luong, A., Rodríguez, A., Kheradmand, F., & Corry, D. B. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.05.002 · Cited by 51
He, X., Xie, J., Wang, Y., Fan, X., Su, Q., Sun, Y., Lei, N., Zhang, D., Gao, G., & Pan, W. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006957 · Cited by 43
Cho, S.-H., Kim, H., Lee, W., Han, E. J., Kim, S.-Y., Fernando, I. P. S., Ahn, G., & Kim, K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106146 · Cited by 47
Yap, G. S., & Gause, W. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02135 · Cited by 49
“In the mouse response to Schistosome infection, IL-33, IL-25, and TSLP can play partially redundant roles, with one essentially substituting for the other (47).”
BackgroundAre ILC 2s Jekyll and Hyde in airway inflammation?
Ealey, K. N., Moro, K., & Koyasu, S. (2017) · Immunological Reviews · doi:10.1111/imr.12547 · Cited by 42
Early Events Triggering the Initiation of a Type 2 Immune Response
El-Naccache, D. W., Haskó, G., & Gause, W. C. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.11.006 · Cited by 40
Innate lymphoid cells in organ fibrosis
Mikami, Y., Takada, Y., Hagihara, Y., & Kanai∥, T. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.07.002 · Cited by 41
Type 2 immunity: a two-edged sword in schistosomiasis immunopathology
Aziz, N. A., Musaigwa, F., Mosala, P., Berkiks, I., & Brombacher, F. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.005 · Cited by 43
Perivascular stromal cells: Directors of tissue immune niches
Sbierski‐Kind, J., Mroz, N. M., & Molofsky, A. B. (2021) · Immunological Reviews · doi:10.1111/imr.12984 · Cited by 39
Loh, Z., Fitzsimmons, R. L., Reid, R. C., Ramnath, D., Clouston, A. D., Gupta, P. K., Irvine, K. M., Powell, E. E., Schroder, K., Stow, J. L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14768 · Cited by 36
“…alarmins, such as IL‐25, IL‐33, or their combination, resulting in increased local proliferation of these cells and increased production of IL‐5, IL‐9, and IL‐13 that activate downstream type 2 effector immune cells and HSCs (Gieseck et al., 2018; Hart et al., 2017; Vannella et al., 2016).”
BackgroundCheng, W., Su, J., Hu, Y., Huang, Q., Shi, H., Wang, L., & Ren, J. (2017) · Europe PMC (PubMed Central) · Cited by 35
Gracias, D. T., Sethi, G. S., Mehta, A. K., Miki, H., Gupta, R. K., Yagita∥, H., & Croft, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.037 · Cited by 39
Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis
Raza, G. S., Sodum, N., Kaya, Y., & Herzig, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112954 · Cited by 38
The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases
Liu, M., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00695 · Cited by 37
“For example, thymic stromal lymphopoietin, IL-25, and IL-33 are important activators of ILC2s, and simultaneous disruption of the three factors successfully alleviated IL-13-dependent liver inflammation and fibrosis during chronic Schistosoma mansoni infection (99).”
BackgroundYombo, D. J. K., Mentink‐Kane, M. M., Wilson, M. S., Wynn, T. A., & Madala, S. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009145 · Cited by 33
Self-citationFan, L., Li, W., Ma, J., Cheng, M., Xie, L., Ye, Z., Xie, Y., Wang, B., Yu, L., Zhou, Y., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151965 · Cited by 31
The role of interleukin-33 in organ fibrosis
Carmine, S. D., Scott, M. M., McLean, M. H., & McSorley, H. J. (2022) · Discovery Immunology · doi:10.1093/discim/kyac006 · Cited by 36
“In models of asthma and parasitic infections, blocking any of IL-25, IL-33, or TSLP alone showed only modest results, while combinatorial targeting of IL-33, IL-25 and TSLP significantly reduced collagen expression and fibrosis [123].”
BackgroundILC2s—Trailblazers in the Host Response Against Intestinal Helminths
Bouchery, T., Gros, G. S. L., & Harris, N. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00623 · Cited by 37
“Lastly, redundancy between all three cytokines has been observed in the context of fibrosis and chronic intestinal inflammation (37).”
BackgroundHirahara, K., Aoki, A., Morimoto, Y., Kiuchi, M., Okano, M., & Nakayama, T. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00735-6 · Cited by 30
Pellefigues, C., Tang, S., Schmidt, A., White, R. F., Lamiable, O., Connor, L. M., Ruedl, C., Dobrucki, J. W., Gros, G. S. L., & Ronchese, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01575 · Cited by 32
“Indeed, IL25, IL33, and TSLP can each contribute redundantly to the optimal Th2 immune response in various organs and contexts, possibly compensating for the effects of TLR4-dependent IFN-I secretion (5).”
BackgroundThe common γ-chain cytokine IL-7 promotes immunopathogenesis during fungal asthma
Reeder, K. M., Dunaway, C. W., Blackburn, J. P., Yu, Z., Matalon, S., Hastie, A. T., Ampleford, E. J., Meyers, D. A., & Steele, C. H. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0028-1 · Cited by 29
The Concept of Pathogenic TH2 Cells: Collegium Internationale Allergologicum Update 2021
Bertschi, N., Bazzini, C., & Schlapbach, C. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000515144 · Cited by 27
IL-33/IL-33R in various types of carotid artery atherosclerotic lesions
Stankovic, M., Ljujić, B., Babić, S., Maravić-Stojkovic, V., Mitrović, S., Arsenijević, N., Radak, D. J., Pejnovic, N. N., & Lukić, M. L. (2019) · Cytokine · doi:10.1016/j.cyto.2019.05.010 · Cited by 26
Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets
Hansi, R. K., Ranjbar, M., Whetstone, C. E., & Gauvreau, G. M. (2024) · Biomedicines · doi:10.3390/biomedicines12102312 · Cited by 34
“Furthermore, TSLP/IL-33 knockout mice treated with anti-IL-25 antibody during the initiation of allergic airway inflammation exhibit a reduction in mucus production, lung remodeling and inflammation [48].”
BackgroundNovel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
Wan, M., Han, J., Ding, L., Hu, F., & Gao, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.604894 · Cited by 30
IL-33–ILC2 axis in the female reproductive tract
Miller, J. E., Koti, M., & Tayade, C. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.006 · Cited by 27
Gu, S., Wang, R., Zhang, W., Wen, C., Chen, C., Liu, S., Lei, Q., Zhang, P., & Zeng, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1436437 · Cited by 36
Innate Lymphoid Cells in Helminth Infections—Obligatory or Accessory?
Löser, S., Smith, K. A., & Maizels, R. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00620 · Cited by 29
“mansoniinduced type-2 pathology in both the lung and the liver (110).”
BackgroundIL-25 Receptor Signaling Modulates Host Defense against Cryptococcus neoformans Infection
Hansakon, A., Jeerawattanawart, S., Pattanapanyasat, K., & Angkasekwinai, P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000073 · Cited by 23
Monocyte and Macrophage-Mediated Pathology and Protective Immunity During Schistosomiasis
Souza, C. O. S., Gardinassi, L. G., Rodrigues, V., & Faccioli, L. H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01973 · Cited by 28
“mansoni is not affected by the lack of TSLP, IL-25, and IL-33 signaling individually, but disruption of signaling by all three mediators reduced hepatic fibrosis, eosinophils, and innate lymphoid cell (ILC)-2 in the liver of mice (Vannella et al., 2016).”
BackgroundLi, Z., Xiao, L., Lin, G., Tang, J., Chen, Y., Chen, L., Li, B., Wu, M., Liu, S., Huang, C., et al. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3542-4 · Cited by 23
Huang, J., Bai, X., Stewart, W., Xu, X., & Zhang, X. (2025) · Nature Communications · doi:10.1038/s41467-025-61114-4 · Cited by 27
“Asthma is a chronic, heterogeneous disease with multiple underlying pathophysiological mechanisms, making single-drug therapy often insuf fi cient to alleviate its diverse symptoms 1,41 .”
Kim, B. E., Hui-Beckman, J. W., Lyubchenko, T. A., Hall, C. F., Fallahi, S., Brull, A., Goleva, E., & Leung, D. Y. M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.027 · Cited by 22
El-Naccache, D. W., Chen, F., Palma, M., Lemenze, A. D., Fischer, M., Wu, W., Mishra, P. K., Eltzschig, H. K., Robson, S. C., Virgilio, F. D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111150 · Cited by 22
“…et al., 2020; Shimokawa et al., 2017; Humphreys et al., 2008), while others indicate a more minor contribution (Zaiss et al., 2013), suggesting that there are likely multiple pathways contributing to helminth-induced type 2 immunity (Vannella et al., 2016; Mcginty et al., 2020; Gause et al., 2020).”
Epithelial Cell Regulation of Allergic Diseases
Gour, N., & Lajoie, S. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0640-7 · Cited by 24
New perspectives on the regulation of type II inflammation in asthma
Becerra-Díaz, M., Wills-Karp, M. A., & Heller, N. M. (2017) · F1000Research · doi:10.12688/f1000research.11198.1 · Cited by 24
Mukendi, J. P. K., Nakamura, R., Uematsu, S., & Hamano, S. (2021) · Parasites & Vectors · doi:10.1186/s13071-020-04561-w · Cited by 30
Reißing, J., Berres, M., Strnad, P., Wree, A., Inzaugarat, M. E., Trautwein, C., Bruns, T., & Zimmermann, H. W. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.011 · Cited by 21
Role of TRPV1 and TRPA1 in TSLP production in nasal epithelial cells
Li, J., Wang, F., Meng, C., & Zhu, D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111916 · Cited by 20
Role of Innate lymphoid Cells in Obesity and Insulin Resistance
Chen, H., Sun, L., Feng, L., Yin, Y., & Zhang, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.855197 · Cited by 28
“ILC2-derived IL-13 activates HSC through IL-4R and STAT6-dependent signaling and thus mediates hepatic fibrosis (109, 110).”
BackgroundXu, X., Dai, H., & Zhang, J. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13541 · Cited by 18
“However, these synergistic effects should be further assessed in other fibrotic murine models.(43) In conclusion, IL-25/IL-33/TSLP may be the master switch that drives the abnormal epithelial–mesenchymal crosstalk in IPF according to preclinical studies.”
BackgroundAravindhan, V., & Anand, G. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0236 · Cited by 25
van Rijt, L. S., Logiantara, A., Canbaz, D., & van Ree, R. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13254 · Cited by 20
“These data indicate that in the presence of Th2 cells, these innate cytokines are not necessary for the maintenance of remodelling.(31) Our data complement these studies, showing that despite a strong inhibition of Th2 cells remodelling of the airways persisted, possibly due to elevated levels of IL‐33 and IL‐25.”
Result
Metadata
- Authors
- Vannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., Comeau, M. R., Smith, D. E., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Amgen (United States) (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-05-04
- Volume
- 8
- Issue
- 337
- Pages
- 337ra65-337ra65
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2345448809
- Cited by
- 188
- References
- 64
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 21 · 2021: 18 · 2020: 19 · 2019: 24 · 2018: 20 · 2017: 25 · 2016: 4
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Intramural Research Program of NIH
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Keywords
- thymic stromal lymphopoietin, IL-25, IL-33, ST2, type 2 inflammation, fibrosis, helminthiasis, Schistosoma mansoni, lung granulomas, eosinophils, ILC2, IL-13, IL-4, allergic lung inflammation, house dust mites, mucus production, lung remodeling, monoclonal antibodies
- MeSH terms
- Interleukin-33, Thymic Stromal Lymphopoietin, Animals, Antibodies, Monoclonal, Female, Fibrosis, Granuloma, Inflammation, Lung Neoplasms, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Schistosoma mansoni, Interleukin-4, Cytokines, Mice, Knockout, Interleukin-13, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.